MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-MH-33-0068074
Freyn Pharmaceuticals Private Limited
Freyn Pharmaceuticals Private Limited - pharma in Thane, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹1.57 Cr
▲ 62% YoY
Net profit · FY 2024
₹1.67 Lakh
Net margin 1.1%
EBITDA · FY 2024
₹12.69 Lakh
EBITDA margin 8.1%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
8 yrs
Est. 2018
Directors on board
2
As per MCA filings
Active GSTINs
1
GST registered
About Freyn Pharmaceuticals Private Limited
Data last updated:
Freyn Pharmaceuticals Private Limited is a private limited company based in Thane, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 22 February 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U74999MH2018PTC305415. Its GSTIN is 27AADCF3148G1ZR (Maharashtra).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Ajit Rambahal Singh and Astha Singh.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Gala No. 2 Shankar Chhaya Lokmanya Ngr Pada – 3 Thane 400606, Maharashtra, India – 400606.
As per the financials filed for FY 2024, the company reported a revenue of ₹1.57 Cr, a growth of 62% compared to the previous year. For the same year it recorded a net profit of ₹1.67 Lakh (net margin 1.1%) and EBITDA of ₹12.69 Lakh (EBITDA margin 8.1%). Revenue has grown at a compounded annual rate (CAGR) of 80% over three years and 70% over five years.
Court records list 1 case involving the company, including 1 filed against it; 1 case is pending.
Freyn Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-33-0068074).
Company details
CIN U74999MH2018PTC305415
Registration Number 305415
Incorporation Date 22 February 2018
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
MSME Classification Micro
Udyam Registration UDYAM-MH-33-0068074
Key People
Ajit Rambahal Singh Director Astha Singh Director Recognitions & Rankings of Freyn Pharmaceuticals
Contact details
Freyn Pharmaceuticals Private Limited's registered office is in Thane, Maharashtra. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressGala No. 2 Shankar Chhaya Lokmanya Ngr Pada – 3 Thane 400606, Maharashtra, India – 400606
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Freyn Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Freyn Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Freyn Pharmaceuticals is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers wholesale and retail trade and repair of motor vehicles and motorcycles.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Wholesale and retail trade; repair of motor vehicles and motorcycles | 45 | Wholesale and retail trade and repair of motor vehicles and motorcycles |
To see the full business activity and turnover split of Freyn Pharmaceuticals Private Limited, buy the company report.
Financials of Freyn Pharmaceuticals Private Limited
FY 2025 filings availableFreyn Pharmaceuticals Private Limited reported revenue of ₹1.57 Cr (up 62% YoY) for FY 2024.
Revenue · FY 2024
₹1.57 Cr ▲ 62%
Net profit · FY 2024
₹1.67 Lakh margin 1.1%
EBITDA · FY 2024
₹12.69 Lakh margin 8.1%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 62%
3 years · compounded
▲ 80%
5 years · compounded
▲ 70%
EBITDA CAGR growth
1 year
▲ 83%
3 years · compounded
▲ 123%
5 years · compounded
▲ 105%
Revenue has grown at a compounded annual rate (CAGR) of 70% over five years, including 62% growth in the latest year. EBITDA rose 83% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹12.69 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹1.67 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 8.1% | ||||
| Net Profit Margin | 1.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Freyn Pharmaceuticals Private Limited, buy the company report.
Board of directors of Freyn Pharmaceuticals Private Limited
Freyn Pharmaceuticals has 2 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ajit Rambahal Singh | Director | 22 Feb 2018 | 8 Years 8 Months | Current |
| Astha Singh | Director | 22 Feb 2018 | 8 Years 8 Months | Current |
Auditor
Freyn Pharmaceuticals Private Limited is audited by CHIRAG DOSHI & CO for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| CHIRAG DOSHI & CO | FY 2022 | 142184W |
Shareholding
The shareholding of Freyn Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2022, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Freyn Pharmaceuticals Private Limited, buy the company report.
Legal cases
Freyn Pharmaceuticals Private Limited has 1 court case on record: 1 filed against it. All case is pending.
Total cases
1
Filed against the company
1
Pending
1
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 1 | 1 | 1 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court, MAHARASHTRA | Court case (CRR) | Filed against the company by Aristo Pharmaceuticals Private Limited | Pending |
To see the full case history of Freyn Pharmaceuticals Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Freyn Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Freyn Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AADCF3148G1ZR | Maharashtra | Active | 10 Apr 2018 |
To see the full GST registrations and return filing status of Freyn Pharmaceuticals Private Limited, buy the company report.
Recent activity
Freyn Pharmaceuticals Private Limited has 2 board changes on record since 2018: 2 appointments. The latest: Ajit Rambahal Singh was appointed as Director on 22 Feb 2018.
AGM
Freyn Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Freyn Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai Ii.
Appointed
Ajit Rambahal Singh was appointed as Director.
Appointed
Astha Singh was appointed as Director.
Incorporation
22 Feb 2018
Freyn Pharmaceuticals Private Limited was registered on 22 Feb 2018 with Roc Mumbai Ii & aged 8 years 8 months as per MCA records.
Frequently asked questions
Freyn Pharmaceuticals is an active private limited company based in Thane, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 22 February 2018 (8+ years old) and is registered under CIN U74999MH2018PTC305415.
Freyn Pharmaceuticals has 2 current directors:
- Ajit Rambahal Singh - Director
- Astha Singh - Director
The latest financial statements of Freyn Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2018 are in the company report.
The GSTIN of Freyn Pharmaceuticals is 27AADCF3148G1ZR, registered in Maharashtra.
The CIN (Corporate Identification Number) of Freyn Pharmaceuticals is U74999MH2018PTC305415. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Freyn Pharmaceuticals has 1 court case on record: 1 filed against it. 1 is pending.
Freyn Pharmaceuticals was incorporated on 22 February 2018, making it 8+ years old. It is registered with the Registrar of Companies, Mumbai.
Ajit Rambahal Singh was appointed as Director on 22 Feb 2018. Astha Singh was appointed as Director on 22 Feb 2018.
Yes, Freyn Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-MH-33-0068074).
The registered office of Freyn Pharmaceuticals is at Gala No. 2 Shankar Chhaya Lokmanya Ngr Pada – 3 Thane 400606, Maharashtra, India – 400606.